HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Prevalence of endogenous uveitis in Kagoshima Prefecture, Southwest Japan].

Abstract
To estimate the current trend in prevalence of endogenous uveitis and HTLV-I-associated uveitis (HAU) in a local area, we sent questionnaires to all ophthalmologic clinics in Kagoshima Prefecture, southern Japan, which has a population of 1.8 million, with reference to uveitis patients seen during May-July 1993 and May-June 1994. Answers to the questionnaires were obtained from about half of the ophthalmologists in each survey session. The proportion of uveitis cases was on the average 0.4% of outpatients, and the prevalence of uveitis was estimated to be 40.4 x 10(-5). The major uveitis entity consisted of toxoplasmosis (7.8%), Vogt-Koyanagi-Harada disease (5.0%), Behçet's disease (4.1%), sarcoidosis (3.4%), and 71.3% of unclassified cases. An additional study for the infection with HTLV-I revealed that the seropositivity for anti-HTLV-I antibodies was 11 (17.5%) of 63 patients with distinct uveitis entities and 38 (30.4%) of 125 patients with etiologically undefined uveitis, indicating no significant difference in HTLV-I infection between the two groups. The prevalence of HAU was estimated to be 8.8 x 10(-5).
AuthorsK Nakao, N Ohba
JournalNippon Ganka Gakkai zasshi (Nippon Ganka Gakkai Zasshi) Vol. 100 Issue 2 Pg. 150-5 (Feb 1996) ISSN: 0029-0203 [Print] Japan
PMID8851155 (Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • HTLV-I Infections (epidemiology)
  • Humans
  • Japan (epidemiology)
  • Prevalence
  • Uveitis (epidemiology, virology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: